Patent · US Active

H3.3 CTL peptides and uses thereof

US10441644B2 · kind B2 · utility

3Cited by
20References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2017
Grant dateOct 15, 2019
Priority date—
Expiry dateJun 5, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/47
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptides that generate an immune response to glioma-related H3.3 proteins and methods of their use are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.